ANLN, a homolog of anillin whose stability and nuclear localization are regulated by the PI3K/AKT pathway, can bind to and activate RHOA, thus promoting cancer growth and development (Suzuki et al., 2005). The gene discussed is AKT1; the disease is cancer.